92104-90-0

Usage

Uses

Used in Pharmaceutical Development:
1-(3-(4-bromophenoxy)propyl)pyrrolidine is used as a building block for the development of pharmaceuticals due to its potential pharmacological properties. Its ability to bind to specific receptors or inhibit enzymes makes it a promising candidate for creating new drugs.
Used in Agrochemicals:
In the agrochemical industry, 1-(3-(4-bromophenoxy)propyl)pyrrolidine is used as a building block for the development of new agrochemicals, potentially enhancing the effectiveness of pesticides or other agricultural products.
Used in Medicinal Chemistry Research:
1-(3-(4-bromophenoxy)propyl)pyrrolidine is employed as a key compound in medicinal chemistry research, where its unique structure and potential interactions with biological targets are explored to advance the understanding of various diseases and their treatment.
Used in Chemical Research:
1-(3-(4-broMophenoxy)propyl)pyrrolidine is also utilized in broader chemical research, where its reactivity, structural properties, and potential to form new derivatives are investigated for various applications beyond the pharmaceutical and agrochemical industries.

Upstream product

• 106-41-2 4-bromo-phenol 
• 57616-69-0 1-(3-chloropropyl)pyrrolidine hydrochloride 
• 39743-20-9 1-(3-chloropropyl)pyrrolidine 

Relevant academic research and scientific papers

1,3-DIHYDROIMIDAZO[4,5-C]CINNOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER

The specification generally relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, where R1-R4, A and X have the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted 1,3-dihydroimidazo[4,5-c]cinnolin-2-one compounds and pharmaceutically acceptable salts thereof; and kits comprising such compounds and salts.

IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER

The specification generally relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, where x, R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.

Synthesis and preliminary evaluation of novel analogues of quindolines as potential stabilisers of telomeric G-quadruplex DNA

Telomeric DNA is a potential selective target for cancer therapy since the tumour-associated enzyme telomerase regulates telomere maintenance in most cancer cells. The 3′ single-stranded ends of telomeric DNA can be folded into quadruplex structures by appropriate small molecules. We describe the preparation of a new class of 2,7-disubstituted 10H-indolo[3,2-b]quinolines with enhanced selectivity for the stabilisation of quadruplex DNA compared to duplex DNA, and also the preparation of a key intermediate for the synthesis of trisubstituted quindolines.